Celexa is an anti-depressant (Citalopram) of the selective serotonin reuptake inhibitor (SSRI) class, manufactured by Forest Laboratories. The U.S Food and Drug Administration (FDA) approved the use of Celexa on July 17, 1998, for the treatment of depression. Its “off-label” uses are for Obsessive-Compulsive Disorder, Panic disorder, Premenstrual Dysphoric Syndrome, Anxiety disorders, Post-traumatic Stress Disorder, and Eating disorders. Since Celexa entered the market, it has been linked to hazardous complications like birth defects and risk of autism in children born to mothers who had taken this drug during pregnancy.
In 2004, Celexa was transferred from Category B to Category C of pregnancy safety criteria, as it indicated a higher risk of fetal abnormality.